No categories

: ' Purdue Pharma'

FDA Stops Generic OxyContin

By Pat Anson, Editor The Food and Drug Administration late today approved new labeling for the painkiller OxyContin that allows Purdue Pharma to maintain its monopoly on the drug by blocking generic versions from entering the [...]

New Wave of Drug Abuse Feared if Generic Oxycodone Sold in Canada

Canadian police, doctors and public health officials are warning the “streets would be flooded” with cheap generic versions of oxycodone if Canada’s Health Minister doesn’t reconsider her decision not to ban them. Drug maker Purdue Pharma’s [...]

West and Southeast Lead Nation in Opioid Prescribing

The western, southeast and Appalachian regions of the United States lead the nation in the prescribing of opioid painkillers, according to new research published in The Journal of Pain. In a study of 205 million opioid [...]

PROP’s Petition: Why Opioid Labeling Changes Are Needed

By Pete Jackson, Guest Columnist Recently, several columns have appeared in American News Report expressing negative views toward a petition submitted to the FDA by doctors, researchers and public health officials, many of them associated with [...]

Head of Pain Society says Furor over Addiction Hurting Patients and Fundraising

Roger B. Fillingim, PhD, professor and director, Pain Research and Intervention Center of Excellence at the University of Florida, recently became president of the American Pain Society(APS). About 3,200 physicians, nurses, psychologists, scientists, pharmacists and others [...]

FDA’s Painkiller Education Campaign Criticized

Two pain management physicians are criticizing plans by the Food and Drug Administration for a voluntary educational campaign for doctors on the risks and benefits of prescribing opioid painkillers. The FDA’s risk evaluation and mitigation strategy [...]